Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Our previous studies have found that Shuangyu Tiaozhi Decoction (SYTZD) could produce an improvement in NAFLD-related indicators, but the underlying mechanism associated with this improvement remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Guoliang, Liang, Hongyi, Sun, Wenxiu, Zhang, Shizhao, Feng, Yanan, Liang, Pengpeng, Chen, Suwen, Liu, Xiangyi, Pan, Wenchao, Zhang, Fengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727266/
https://www.ncbi.nlm.nih.gov/pubmed/36506575
http://dx.doi.org/10.3389/fphar.2022.1016745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727266/
https://www.ncbi.nlm.nih.gov/pubmed/36506575
http://dx.doi.org/10.3389/fphar.2022.1016745

Ejemplares similares